Differences in perception of breast cancer treatment between patients, physicians, and nurses and unmet information needs in Japan

Sakai, Haruna; Umeda, Megumi; Okuyama, Hiromi; Nakamura, Seigo

doi:10.1007/s00520-019-05029-z

Cited by 24 publications

(40 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Efforts have been made to investigate the information needs of women with breast cancer (Table 1). The majority of studies are crosssectional (10)(11)(12)(13)(14)(15)(16)(17)(18) with several literature reviews and metasyntheses (19,20). The research is varied, investigating the information needs of women during and post treatment (10)(11)(12)15,21).…”

Section: Information Needsmentioning

confidence: 99%

“…The majority of studies are crosssectional (10)(11)(12)(13)(14)(15)(16)(17)(18) with several literature reviews and metasyntheses (19,20). The research is varied, investigating the information needs of women during and post treatment (10)(11)(12)15,21). Some studies have focussed on younger women with breast cancer (13,16), whilst others have focussed on long term survivors (19) and those managing advanced (17) and metastatic breast cancer (14).…”

Section: Information Needsmentioning

confidence: 99%

“…Populations investigated were diverse including women from Lebanon (10), Ireland (11), Japan (12,16), America (13,14), Canada (22), Malaysia (21), Spain (15), United Kingdom (23), Australia (17) and Iranian immigrants (18). Unfortunately, most studies used relatively small sample sizes ranging from 19 participants (22) to 207 (12) making the accuracy of the insights difficult to interpret.…”

Section: Information Needsmentioning

confidence: 99%

“…Common findings from the studies reviewed included variation in information needs based on age (10,16,19), a general preference to receive information directly from the healthcare provider (10,12,17,20), and a desire for high-quality information related to recovery and prognosis (11,14,15,20,21). health technology (DHT), and a key component of usercentred design, is the use of personas.…”

Section: Information Needsmentioning

confidence: 99%

“…The information requirements of these two groups are different. Those currently receiving treatment express a greater need for information related to treatment plans and side-effects ( 21), whilst those under long term follow up require help with social and physical rehabilitation (12,15), and information related to prognosis (14).…”

Section: A Common Tool For Both the Design And Evaluation Of Digitalmentioning

confidence: 99%

See 4 more Smart Citations

Evaluation of two mobile health apps for patients with breast cancer using the Mobile Application Rating Scale

Wright¹

2021

mHealth

View full text Add to dashboard Cite

According to estimates of cancer incidence and mortality, breast cancer is the most frequently diagnosed cancer in 135 countries and the leading cause of cancer related mortality in over 100 (1). Globally, over 2 million cases of breast cancer are diagnosed each year, accounting for almost 1 in 4 cases of cancer in women. In the UK and the US, it is estimated that between 1 in 7 and 1 in 8 women will develop breast cancer in their lifetime (2,3). UK breast cancer policyEarlier detection through screening has helped improve breast cancer mortality. The UK breast cancer screening programme was the first of its kind and began in 1988. Through the programme, women aged 50-70 can receive

show abstract

Section: Information Needsmentioning

confidence: 99%

Section: Information Needsmentioning

confidence: 99%

Section: Information Needsmentioning

confidence: 99%

Section: Information Needsmentioning

confidence: 99%

Section: A Common Tool For Both the Design And Evaluation Of Digitalmentioning

confidence: 99%

See 3 more Smart Citations

Evaluation of two mobile health apps for patients with breast cancer using the Mobile Application Rating Scale

Wright¹

2021

mHealth

View full text Add to dashboard Cite

show abstract

Cross‐sectional study of therapy‐related expectations/concerns of patients with metastatic renal cell carcinoma and physicians in Japan

Kimura,

Fujii,

Osawa

et al. 2024

Cancer Medicine

View full text Add to dashboard Cite

ObjectiveTo achieve patient‐centricity in metastatic renal cell carcinoma (mRCC) treatment, it is essential to clarify the differences in perspectives between patients and physicians. This cross‐sectional analysis of a web survey aimed to clarify the differences in expectations and concerns between mRCC patients and physicians regarding systemic mRCC therapy in Japan.MethodsSurveys from 83 patients and 165 physicians were analyzed.ResultsThe top three most significant differences in expectations of systemic therapy between patients and physicians (patient‐based physician value) were “Chance of achieving treatment‐free status” (−30.1%, p < 0.001), “Longer survival” (+25.8%, p < 0.001), and “Chance of eliminating all evidence of disease” (−25.6%, p < 0.001). The top three most significant differences in concerns for systemic therapy between patients and physicians (patient‐based physician value) were “Lack of efficacy” (+36.1%, p < 0.001), “Lack of knowledge of treatment” (−28.2%, p < 0.001), and “Daily activities affected by side effects” (+22.3%, p < 0.001). Diarrhea, fatigue/malaise, and nausea/vomiting were patients' most distressing adverse events; 50.6% of patients had difficulty telling their physicians about adverse events such as fatigue, anxiety, and depression.ConclusionsThis study demonstrated a gap between patients with mRCC and physicians in their expectations and concerns for systemic therapy. Japanese patients with mRCC suffer from a number of adverse events, some of which are not shared with physicians. This study highlights the importance of communicating well with patients in clinical practice to achieve patient‐centricity in systemic treatment for mRCC.

show abstract

Consistency between patients and families in recognizing cancer chemotherapy side effects: A questionnaire survey

et al. 2021

View full text Add to dashboard Cite

Background: Although the side effects of cancer chemotherapy impair a patient's quality of life, family members' awareness of side effects may relieve patient anxiety and distress.Aim: We investigated whether patients and their families were consistent in recognizing the occurrence and severity of symptomatic side effects of chemotherapy treatment for cancer.Methods and results: This was a prospective observational study. We administered a questionnaire survey to patients and family members to assess the frequency of occurrence (1: never, 2: almost never, 3: sometimes, 4: frequently, 5: almost always, 6: unknown) and the degree of severity (1: mild, 2: moderate, 3: severe, 4: extremely severe, 5: unknown) of physical and psychological symptoms associated with cancer chemotherapy. Weighted Kappa and Cramer coefficients were used to assess consistency between the two groups. We surveyed 20 pairs of patients (5 men, 15 women) and their families (10 men, 10 women); 17 pairs lived together. The median age was 65.5 years (interquartile [IQR], 58.75, 69.25) for patients and 61.00 years (IQR, 47.25, 71.25) for family members. Of patients, 17 had solid cancer, and three had leukemia. Family members mostly recognized objectively visible symptoms such as hair loss and development of spots and keratinization. However, it was difficult for families to detect invisible subjective symptoms such as weakness, dysesthesia, depressed mood, and unarticulated anxiety. Conclusions:The results indicated that recognition of invisible subjective symptoms in patients undergoing chemotherapy was difficult even for family members. Therefore, a multidisciplinary approach in which various medical professionals actively communicate with both patients and families is important. Information sharing in collaboration with patients and families could increase understanding of the patient's condition and optimize patient care.

show abstract

Differences in perception of breast cancer treatment between patients, physicians, and nurses and unmet information needs in Japan

Cited by 24 publications

References 18 publications

Evaluation of two mobile health apps for patients with breast cancer using the Mobile Application Rating Scale

Evaluation of two mobile health apps for patients with breast cancer using the Mobile Application Rating Scale

Cross‐sectional study of therapy‐related expectations/concerns of patients with metastatic renal cell carcinoma and physicians in Japan

Consistency between patients and families in recognizing cancer chemotherapy side effects: A questionnaire survey

Contact Info

Product

Resources

About